Purpose: The patterns of angiotensin II-receptor blocker (ARB) therapy in patients with and without a history of antihypertensive use were studied.Methods. Data for this retrospective cohort study ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...

A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well ...

A new multicenter study that recently appeared on the medRxiv* preprint server in November 2020 has found a lower or equal risk of fatal coronavirus disease 2019 (COVID-19) in hypertensive patients, ...

Hypertension is a prevalent and often asymptomatic chronic disease. The goal of antihypertensive treatment is to prevent associated complications and improve cardiovascular morbidity and mortality. To ...

Please provide your email address to receive an email when new articles are posted on . Renin-angiotensin-aldosterone system (RAAS) inhibitors conferred reduced risks for starting dialysis or needing ...

Continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before non-cardiac surgery is linked to a reduced risk of postoperative mortality and functional decline, ...

Please provide your email address to receive an email when new articles are posted on . Certain antihypertensive medications may help prevent cognitive decline, according to results of a cohort study ...

Common drugs used in high blood pressure, heart failure, and diabetic patients with kidney damage, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), ...

Obstructive sleep apnea (OSA), a common complication of obesity, plays an important role in the development of hypertension. Mechanisms include intermittent hypoxia, oxidative stress, increased ...